Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 2]
This is a Phase 2 clinical trial assessing relacorilant with nab-paclitaxel and gemcitabine for metastatic pancreatic ductal adenocarcinoma.…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trials evaluating elironrasib and daraxonrasib as solo therapies and in combination for advanced KRAS G12C-mutant…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial evaluating the combination of gemcitabine, erlotinib, and nab-paclitaxel in basal-like pancreatic …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study for AZD4360 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 clinical trial of AZD4360 in adults with advanced solid tumors, including gastric cancer and gastroesophageal junction cancer, is …
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors [Phase 1]
Phase 1 update on LY4066434, a pan-KRAS inhibitor, in KRAS-mutant solid tumors, including pancreatic ductal adenocarcinoma and non-small cel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 2]
A Phase 2 clinical trial update on Nuzefatide Pevedotin (BT5528) for metastatic pancreatic ductal adenocarcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors [Phase 1, Phase 2]
Verastem is evaluating the KRAS G12D-mutated cancer drug VS-7375 in a Phase 1/2 study across several solid tumors, including pancreatic duct…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients [Phase 1, Phase 2]
Clinical trial update for TNG462 in combination therapy for pancreatic ductal adenocarcinoma and non-small cell lung cancer, currently recru…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Pancreatic Cancer Early Detection Consortium
The Pancreatic Cancer Early Detection Consortium trial is currently recruiting to study early detection of pancreatic cancer and related pan…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for patients with resectable or borderline resectab…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Pancreatic Cancer Screening in a Population at High Risk [NA]
A clinical trial update on pancreatic cancer screening in a high-risk population sponsored by Masaryk Memorial Cancer Institute; the study t…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens [NA]
ARTIDIS AG is evaluating nanomechanical signature profiling on pancreatic cancer specimens in a clinical trial. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors [Phase 1]
Phase I study update for the radiopharmaceutical [177Lu]Lu-DFC413 in patients with various solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma [NA]
This clinical trial update describes PDAC-PATHWAYS, a digital informational and supportive care app for patients initiating neoadjuvant ther…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating SGN-CEACAM5C in adults with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC [Phase 2]
Phase 2 clinical trial evaluating AGEN1423 and Botensilimab with or without chemotherapy in advanced pancreatic ductal adenocarcinoma; curre…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 3]
A Phase 3 clinical trial evaluating 18F-FAPI PET imaging to detect metastatic disease in pancreatic ductal adenocarcinoma, currently recruit…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation. [Phase 1]
Pfizer is conducting a Phase 1 study of PF-07934040 in adults with advanced solid tumors carrying a genetic mutation, evaluating the drug al…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors [Phase 1]
Phase 1 trial MOONRAY-01 evaluating LY3962673 in KRAS G12D-mutant solid tumors is currently recruiting. The study appears to include pancrea…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: OSCAR II STUDY - The ONCObind CTC Removal Study [NA]
Update on the OSCAR II Study evaluating the ONCObind circulating tumor cell (CTC) removal device; the trial status is not yet recruiting for…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB) [NA]
This clinical trial aims to develop functional, personalized profiling of biopsied pancreatic tumors (pancreatic ductal adenocarcinoma) usin…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content. [NA]
A clinical trial is evaluating an app that allows pancreatic cancer patients to monitor progress via targeted questionnaires and educational…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation [Phase 1]
This clinical trial update describes a Phase 1 dose-escalation study of the investigational KRAS inhibitor KST-6051 in adults with KRAS-muta…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
This ClinicalTrials.gov entry describes a prospective study hosted by Chang Gung Memorial Hospital that will profile metabolomic and immune-…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI) [Phase 2]
INDIGO-FAPI is a Phase 2 clinical trial investigating PET-FAPI imaging for earlier detection of pancreatic ductal adenocarcinoma, currently …